Catherine Wu on Genetic Profiling: The Key to ... - CLL Support

CLL Support

22,366 members38,466 posts

Catherine Wu on Genetic Profiling: The Key to Personalized CLL Care (Patient Power video)

AussieNeil profile image
AussieNeilAdministrator
2 Replies

I found this a very exciting and interesting video where Andrew Schorr interviews Catherine Wu of the Dana-Farber Cancer Institute in Boston about the promise of precision treatment based on our individual CLL genetics.

"Now that cancer genes have been mapped and the price of genetic testing has decreased, experts are excited about how genetic information can inform more personalized CLL care. Dr. Catherine Wu, a leading Harvard researcher from the Dana-Farber Cancer Institute in Boston, foresees the day when CLL patients will routinely have successive genetic tests to adjust precision treatment and keep up with new cancer gene mutations that a patient might develop."

patientpower.info/video/gen...

Thanks Chris for finding this,

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
2 Replies

Thanks Chris and Neil.

For the future things are looking brighter, however quite away in the future, from research to trial to application. However good to see and hear how research particularly in genetics is moving ahead.

Bub

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin

I think my service is running slow the player keeps stopping. I may have to wait till next week when Dr Anna schuh and team who share this area of specialisation in advancing CLL clinical research and it's application today and tomorrow. is the keynote speaker at the CLL Support Association meeting on the 15th next week. We will get a good insight from her of how she anticipates it will impact on treatment and management and timing here in the UK..

I guess we can get a good update then. the picture is looking very exciting though this kind of technology when translated and affordable and used alongside novel therapies should change the face of CLL medicine. We have to keep pushing for change.while we wait.

You may also like...

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

eport-cll-btk-inhibitors-update? Watch as Jennifer Brown, MD, PhD, Director, CLL Center, Dana...

Introducing Chris Dwyer (Patient Power Video)

once, but here's Andrew Schorr interviewing Chris at the Third International CLL Patient Advocacy...

Patient Power CLL & Fatigue 2022-10-19.

about every patient with chronic lymphocytic leukemia (CLL). In this replay of a recent CLL Answers...

Combination therapy for our CLL

week, I am sharing a video of Dr. Jennifer Brown from Dana Farber Cancer Institute where she...

Expert Access Second Opinion from CLL Society - PRICELESS!

consultation with our CLL expert Dr. Matthew Davids from Dana Farber in Boston. We will be...